The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
Objective: Recent studies have shown that the presence of systemic inflammation and platelet status correlate with poor survival in various cancers. The aim of this study was to evaluate the prognostic value of the preoperative platelet–lymphocyte ratio (PLR) and the neutrophil–lymphocyte ratio (NLR...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-05-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834016638019 |
id |
doaj-db9fbc39cb5d4c4f8db1b8dd13c6aa21 |
---|---|
record_format |
Article |
spelling |
doaj-db9fbc39cb5d4c4f8db1b8dd13c6aa212020-11-25T02:58:19ZengSAGE PublishingTherapeutic Advances in Medical Oncology1758-83401758-83592016-05-01810.1177/1758834016638019The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?Shan ChenJunbing GuoChongjin FengZunfu KeLeihui ChenYunping PanObjective: Recent studies have shown that the presence of systemic inflammation and platelet status correlate with poor survival in various cancers. The aim of this study was to evaluate the prognostic value of the preoperative platelet–lymphocyte ratio (PLR) and the neutrophil–lymphocyte ratio (NLR) in patients with oral squamous cell carcinoma (OSCC) undergoing surgery. Methods: In this study, 306 patients with OSCC who had surgery were enrolled. The optimal cutoff value of PLR and NLR was determined by receiver operating characteristic (ROC) curve analysis. The prognostic significance of both markers was determined by uni- and multivariate analysis. Results: The results showed that high NLR and PLR were classified using a cutoff value of 2.7 and 135, respectively, based on ROC curve analysis. Only PLR was associated with decreased disease-free survival [hazard ratio (HR) = 2.237; 95% confidence interval (CI): 1.401–3.571; p = 0.001] and overall survival [HR = 2.022; 95% CI: 1.266–3.228; p = 0.003] by both uni- and multivariate analysis. Conclusion: The preoperative PLR is superior to NLR as an independent indicator in predicting disease-free survival and overall survival in patients who undergo oral cancer resection for OSCC.https://doi.org/10.1177/1758834016638019 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shan Chen Junbing Guo Chongjin Feng Zunfu Ke Leihui Chen Yunping Pan |
spellingShingle |
Shan Chen Junbing Guo Chongjin Feng Zunfu Ke Leihui Chen Yunping Pan The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Therapeutic Advances in Medical Oncology |
author_facet |
Shan Chen Junbing Guo Chongjin Feng Zunfu Ke Leihui Chen Yunping Pan |
author_sort |
Shan Chen |
title |
The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? |
title_short |
The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? |
title_full |
The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? |
title_fullStr |
The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? |
title_full_unstemmed |
The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? |
title_sort |
preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Medical Oncology |
issn |
1758-8340 1758-8359 |
publishDate |
2016-05-01 |
description |
Objective: Recent studies have shown that the presence of systemic inflammation and platelet status correlate with poor survival in various cancers. The aim of this study was to evaluate the prognostic value of the preoperative platelet–lymphocyte ratio (PLR) and the neutrophil–lymphocyte ratio (NLR) in patients with oral squamous cell carcinoma (OSCC) undergoing surgery. Methods: In this study, 306 patients with OSCC who had surgery were enrolled. The optimal cutoff value of PLR and NLR was determined by receiver operating characteristic (ROC) curve analysis. The prognostic significance of both markers was determined by uni- and multivariate analysis. Results: The results showed that high NLR and PLR were classified using a cutoff value of 2.7 and 135, respectively, based on ROC curve analysis. Only PLR was associated with decreased disease-free survival [hazard ratio (HR) = 2.237; 95% confidence interval (CI): 1.401–3.571; p = 0.001] and overall survival [HR = 2.022; 95% CI: 1.266–3.228; p = 0.003] by both uni- and multivariate analysis. Conclusion: The preoperative PLR is superior to NLR as an independent indicator in predicting disease-free survival and overall survival in patients who undergo oral cancer resection for OSCC. |
url |
https://doi.org/10.1177/1758834016638019 |
work_keys_str_mv |
AT shanchen thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT junbingguo thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT chongjinfeng thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT zunfuke thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT leihuichen thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT yunpingpan thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT shanchen preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT junbingguo preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT chongjinfeng preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT zunfuke preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT leihuichen preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma AT yunpingpan preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma |
_version_ |
1724707105473036288 |